
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group's projected earnings are expected to benefit from a potential 4%-5% boost due to the introduction of new pricing strategies and customer expansion initiatives, particularly through partnerships like FanDuel. The company's anticipation of revenues exceeding $300 million annually from new offerings indicates significant growth opportunities, which could further enhance EPS in 2026 and beyond. With the recent adjustments to EPS forecasts and increased optimism surrounding prediction markets, CME Group's stock outlook remains robust, supported by its strategic acquisitions and its established position in trading and clearing S&P futures contracts.
Bears say
CME Group faces significant regulatory risks that may lead to reduced trading volumes, as potential changes in margin requirements and speculation limitations are under consideration by regulators. Additionally, uncertainties surrounding customer demand, competitive positioning, and unforeseen developments in management or accounting practices could adversely impact anticipated revenues and earnings. The firm's exposure to credit risk from third-party clearing members also poses a threat to its working capital, further complicating its financial outlook.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares